Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Rami S Komrokji

Showing results (11-20 of 204) with videos related to

Pageof 21
Sort By:
Expert Review of Hematology|April 22, 2014
The role of pacritinib in the management of myelofibrosisVu H Duong, Rami S Komrokji
Hematology/Oncology Clinics of North America|April 3, 2010
Lenalidomide for treatment of myelodysplastic syndromes: current status and future directionsRami S Komrokji, Alan F List
Current Hematology Reports|May 4, 2005
The clinical implications of the World Health Organization's classification of myelodysplastic syndromesRami S Komrokji, John M Bennett
Expert Opinion on Biological Therapy|December 2, 2004
The colony-stimulating factors: use to prevent and treat neutropenia and its complicationsRami S Komrokji, Gary H Lyman
Therapeutic Advances in Hematology|January 28, 2021
Treatment options for lower-risk myelodysplastic syndromes. Where are we now?Virginia O Volpe, Rami S Komrokji
Hematology (Amsterdam, Netherlands)|September 29, 2005
The myelodysplastic syndromes: diagnosis, molecular biology and risk assessmentJohn M Bennett, Rami S Komrokji
Current Hematologic Malignancy Reports|April 29, 2010
Who is WHO in myelodysplastic syndromes? Clinical implications of the WHO classificationRami S Komrokji, John M Bennett
Journal of Immunotherapy and Precision Oncology|June 6, 2022
JAK Be Nimble: Reviewing the Development of JAK Inhibitors and JAK Inhibitor Combinations for Special Populations of Patients with MyelofibrosisAndrew T Kuykendall, Rami S Komrokji
Current Pharmaceutical Design|May 11, 2012
Lenalidomide for treatment of myelodysplastic syndromesRami S Komrokji, Alan F List
Expert Review of Hematology|June 15, 2018
Clinical consequences of iron overload in patients with myelodysplastic syndromes: the case for iron chelation therapyJamile M Shammo, Rami S Komrokji
Pageof 21

Showing results (11-20 of 204) with videos related to

Sort By:
Pageof 21
Expert Review of Hematology|April 22, 2014
The role of pacritinib in the management of myelofibrosisVu H Duong, Rami S Komrokji
Hematology/Oncology Clinics of North America|April 3, 2010
Lenalidomide for treatment of myelodysplastic syndromes: current status and future directionsRami S Komrokji, Alan F List
Current Hematology Reports|May 4, 2005
The clinical implications of the World Health Organization's classification of myelodysplastic syndromesRami S Komrokji, John M Bennett
Expert Opinion on Biological Therapy|December 2, 2004
The colony-stimulating factors: use to prevent and treat neutropenia and its complicationsRami S Komrokji, Gary H Lyman
Therapeutic Advances in Hematology|January 28, 2021
Treatment options for lower-risk myelodysplastic syndromes. Where are we now?Virginia O Volpe, Rami S Komrokji
Hematology (Amsterdam, Netherlands)|September 29, 2005
The myelodysplastic syndromes: diagnosis, molecular biology and risk assessmentJohn M Bennett, Rami S Komrokji
Current Hematologic Malignancy Reports|April 29, 2010
Who is WHO in myelodysplastic syndromes? Clinical implications of the WHO classificationRami S Komrokji, John M Bennett
Journal of Immunotherapy and Precision Oncology|June 6, 2022
JAK Be Nimble: Reviewing the Development of JAK Inhibitors and JAK Inhibitor Combinations for Special Populations of Patients with MyelofibrosisAndrew T Kuykendall, Rami S Komrokji
Current Pharmaceutical Design|May 11, 2012
Lenalidomide for treatment of myelodysplastic syndromesRami S Komrokji, Alan F List
Expert Review of Hematology|June 15, 2018
Clinical consequences of iron overload in patients with myelodysplastic syndromes: the case for iron chelation therapyJamile M Shammo, Rami S Komrokji
Pageof 21